telaprevir http://news.stlpublicradio.org en New drugs promise higher cure rates for hepatitis C http://news.stlpublicradio.org/post/new-drugs-promise-higher-cure-rates-hepatitis-c <p><a href="http://stream.publicbroadcasting.net/production/mp3/national/local-national-970849.mp3">http://stream.publicbroadcasting.net/production/mp3/national/local-national-970849.mp3</a></p><p>In the past couple of weeks, the <a href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/">U.S. Food and Drug Administration</a> has approved two new drugs for the treatment of <a href="http://www.cdc.gov/hepatitis/index.htm">hepatitis C</a>, a virus that can cause liver damage and cancer.</p><p>The new drugs should greatly improve cure rates for the more than three million Americans affected by this potentially fatal disease.</p><p> Fri, 27 May 2011 11:00:00 +0000 Véronique LaCapra 1319 at http://news.stlpublicradio.org New drugs promise higher cure rates for hepatitis C New drug to treat hepatitis C approved by FDA http://news.stlpublicradio.org/post/new-drug-treat-hepatitis-c-approved-fda <p>The FDA has approved a new drug for the treatment of hepatitis C, a viral disease that attacks the liver and can lead to cirrhosis and liver cancer.<br /><br />In the U.S., existing medications cure only about 50 percent of patients.<br /><br />Dr. Bruce Bacon of Saint Louis University led a clinical trial for the new drug, boceprevir.</p><p>Bacon says adding boceprevir to the standard two-drug treatment significantly improved cure rates, especially for patients who have been treated before and failed to recover.</p> Fri, 13 May 2011 21:30:33 +0000 Véronique LaCapra 1233 at http://news.stlpublicradio.org New drug to treat hepatitis C approved by FDA